Acquisition of
May 2009
Announced: May 2009Headquarters: San Jose, CA
President and Chief Executive Officer: Masahisa Kitagawa
Executive Vice President and Chief Operating Officer: Ichiro Mori
Teikoku Pharma USA, a wholly-owned subsidiary of Teikoku Seiyaku of Japan, is an international specialty pharmaceutical company developing and manufacturing a variety of medicated patches and ointments for the treatment of skin problems, pain, ulcers, and other conditions. Acting as exclusive buyside advisor, Torreya represented Teikoku in its acquisition of Travanti Pharma, a privately-held corporation that designs, develops and markets drug delivery platforms. The acquisition helps broaden Teikoku’s transdermal delivery capabilities and enhances its pipeline in the areas of pain and CNS. The transaction was Teikoku’s first acquisition since the company was founded in 1848.
Copyright © 2010 Torreya Partners LLC. All rights reserved.
Securities offered through Financial West Group, member FINRA/SIPC. Torreya Partners LLC and Financial West Group are unaffiliated entities.